异基因造血干细胞移植后1型糖尿病由受者残留T细胞驱动:一例报告
本病例报告研究一例单倍体相合造血干细胞移植后发生1型糖尿病的患者,利用供受者HLA差异及II类四聚体技术区分胰岛特异性CD4+ T细胞来源。结果发现,尽管供者T细胞嵌合率达99%,但超过80%的胰岛特异性T细胞受受者独有HLA等位基因限制,提示其来源于受者残留细胞。结论认为该患者移植后1型糖尿病最可能由受者残留自身反应性T细胞驱动。
要点
- 移植后新发1型糖尿病不一定源于供者自身免疫传递,需考虑受者残留自身反应性T细胞。
- 利用HLA差异和II类四聚体可区分胰岛特异性T细胞的供受者来源。
- 即使清髓预处理和反复免疫治疗,已建立的胰岛自身免疫仍可持久存在。
核心结论
- 该患者移植后1型糖尿病最可能由受者残留的胰岛特异性T细胞驱动,而非供者来源自身免疫。
研究设计与样本
- 病例报告:一例单倍体相合造血干细胞移植后发生1型糖尿病的患者,利用供受者HLA差异和II类四聚体分析外周血胰岛特异性CD4+ T细胞。
主要发现
- 四聚体分析显示受者外周血胰岛特异性T细胞扩增,而供者无此类扩增。
- 尽管供者T细胞嵌合率达99%,超过80%的胰岛特异性T细胞受受者独有HLA等位基因限制,提示来源于受者残留细胞。
临床怎么用
- 移植后新发1型糖尿病需鉴别自身免疫来源于供者还是受者残留细胞,HLA四聚体技术可用于溯源。
- 对已存在胰岛自身免疫的受者,移植后仍需关注残留自身反应性T细胞导致的糖尿病风险。
局限性
- 为单例病例报告,结论需在更大样本中验证。
- 原文未报告四聚体检测的具体方法学细节及随访时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Posttransplant type 1 diabetes (T1D) is typically attributed to transferred donor autoimmunity. We investigated a distinct etiology in a patient who developed diabetes following haploidentical hematopoietic cell transplantation, assessing whether autoimmunity originated from donor or residual host cells. RESEARCH DESIGN AND METHODS: Leveraging HLA disparity between the haploidentical donor and recipient, we used HLA class II tetramers to enumerate islet-specific CD4+ T cells in peripheral blood restricted by shared versus recipient-only HLA alleles. RESULTS: Tetramer analysis revealed an expanded population of islet-specific T cells in the recipient. The donor showed no such expansion. Despite 99% donor T-cell chimerism, >80% of the islet-specific T cells were restricted by recipient-unique HLA alleles, suggesting they originated from the residual host fraction. CONCLUSIONS: T1D in this patient was most likely driven by residual recipient-derived T cells. Their survival despite myeloablative conditioning and repeated immunotherapy underscores the remarkable durability of established islet autoimmunity.
引用
- Thelin MA, Cho S, Callebaut A, et al. Type 1 Diabetes Driven by Residual Recipient T Cells After Hematopoietic Cell Transplantation: A Case Report. Diabetes Care. 2026. PMID: 42411999. doi:10.2337/dc26-0795
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。